Advertisement
Advertisement
ELVN
Enliven Therapeutics, Inc. Common Stock
46.09
USDSponsored
-2.10
-4.36%
Sep 23, 16:00 UTC -4
Closed
After-Market
46.09
-0.01
-0.01%
Enliven Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 3.38B |
| Beta | 0.30 |
| Earnings Per Share (EPS) | -1.67 |
| Price-to-Book (P/B) Ratio | 4.00 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -18.55% |
| Current Ratio | 64.07% |
| Free Cash Flow | -37.92M |
